INDCT Induct AS

0.0413USD0.4000 NOK · OSL-2.20%Mkt Cap: 2.08M USDP/E: —

Induct AS develops management software in Norway and internationally. The company offers care pathway platform, a disease specific SaS platform; grant platforms; innovation management; and induct.net platform. Induct AS …

Key Statistics

Company
Market Cap2.08M USD
Enterprise Value1.34M USD
Revenue (TTM)1.25M USD
Gross Profit1.42M USD
Net Income (TTM)-733.69K USD
Revenue/Share0.02 USD
Last Price0.0413 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryNO
SectorHealthcare
IndustryHealth Information Services
ISINNO0010536048
Valuation
P/E (Trailing)—
P/E (Forward)-3.33
PEG—
EV/EBITDA-0.85
EV/Revenue1.07
P/S1.66
P/B0.31
EPS (TTM)-0.04 USD
EPS (Forward)-0.01 USD
52W Range
0.03920% of range0.4955
52W High0.4955 USD
52W Low0.0392 USD
Profitability
Gross Margin92.86%
Oper. Margin-79.85%
EBITDA Margin-125.56%
Profit Margin-48.05%
ROE-17.41%
ROA-12.64%
ROIC-12.78%
ROCE-11.99%
Growth
Revenue Growth-0.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF458.74K USD
CapEx (TTM)799.22K USD
FCF Margin—
FCF Yield—
Net Debt-734.93K USD
Net Debt/EBITDA0.47
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio4.78
Quick Ratio4.78
Book Value/Sh0.13 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.1136 USD
Upside (mean)+175.0%
Target Range0.1136 USD – 0.1136 USD
# Analysts1
Ownership
Shares Out.50.31M
Float32.37M
Insiders39.88%
Institutions1.68%
Technical
SMA 500.0571 (-27.7%)
SMA 2000.1822 (-77.3%)
Beta0.41
S&P 52W Chg8.68%
Avg Vol (30d)211.24K
Avg Vol (10d)252.00K
Technical Indicators
RSI (14)31.3
MACD-0.0473
MACD Signal-0.0404
MACD Hist.-0.0069
BB Upper0.0628 USD
BB Middle0.0500 USD
BB Lower0.0371 USD
BB Width51.44%
ATR (14)0.0050 USD
Vol Ratio (20d)0.83x

About Induct (OSL: INDCT)

›

Induct (OSL: INDCT) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Health Information Services industry, part of the Healthcare sector.

The shares were at 0.4000 NOK on 20 November 2026, down 86.4% over 52 weeks. Its 52-week range is 0.3800 NOK to 4.800 NOK: the price is 91.7% below the high and 5.3% above the low.

Its market capitalisation is 20.12M NOK.

Induct reports return on equity of -17.4%, an operating margin of -79.9% and flat revenue year over year.

It holds more cash than debt, a net cash position of 7.12M NOK. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 1.100 NOK is 175.0% above the current price.